Mechanisms of salvianolic acids in kidney disease therapy: advances and perspectives
Jing Li, Xiaoqin Liu, Haoyue Feng · 2026
Read Mechanisms of salvianolic acids in kidney disease therapy: advances and perspectives by Jing Li, Xiaoqin Liu, Haoyue Feng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13220521.txt.
Description
Jing Li, Xiaoqin Liu, and Haoyue Feng review how salvianolic acids act in kidney disease therapy. Kidney diseases from acute injury to diabetic nephropathy form a major global health burden. Salvianolic acids are water soluble active compounds from the herb Salvia miltiorrhiza, with types A, B, and C the focus of current research.
The review links drug exposure measures to effects and compares the three compounds on strength, target affinity, and pathway specificity across disease models. Low oral bioavailability, fast metabolism, and poor kidney distribution limit all three, above all for long term anti scarring action. Kidney targeted nano delivery and structural modification are proposed as routes to better exposure and stronger protection.
Catalog record
| CREATOR | Jing Li, Xiaoqin Liu, Haoyue Feng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 82 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |